Organon (OGN) EBT Margin (QoQ) (2020 - 2026)
Powered by 
Analysis
Organon (OGN) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -284.00 |
| Mar 31, 2026 | 2,441.00 |
| Dec 31, 2025 | -2,499.00 |
| Sep 30, 2025 | 80.00 |
| Jun 30, 2025 | 769.00 |
| Mar 31, 2025 | -143.00 |
| Dec 31, 2024 | -498.00 |
| Sep 30, 2024 | -154.00 |
| Jun 30, 2024 | 7.00 |
| Mar 31, 2024 | 804.00 |
| Dec 31, 2023 | 124.00 |
| Sep 30, 2023 | -1,053.00 |
| Jun 30, 2023 | 52.00 |
| Mar 31, 2023 | -2,257.00 |
| Dec 31, 2022 | 1,950.00 |
| Sep 30, 2022 | 24.00 |
| Jun 30, 2022 | -1,010.00 |
| Mar 31, 2022 | 1,348.00 |
| Dec 31, 2021 | -959.00 |
| Sep 30, 2021 | -309.00 |